This invention relates to a series of arylsubstituted piperazines, of Formula
I
##STR1##
pharmaceutical compositions containing them and intermediates used
in their manufacture. The compounds of the invention selectively inhibit binding
to the -1a adrenergic receptor, a receptor which has been implicated in
benign prostatic hyperplasia. As such the compounds are potentially useful in the
treatment of this and other disease.
